生細胞カプセル化市場：技術、ポリマー、用途別-2025-2030年の世界予測

生細胞カプセル化市場は、2023年に3億1,229万米ドルと評価され、2024年には3億2,589万米ドルに達すると予測され、CAGR 4.44%で成長し、2030年には4億2,354万米ドルになると予測されています。

生細胞カプセル化は、生きた細胞を半透膜またはカプセルに封じ込め、宿主の免疫システムから保護しながら分子の交換を可能にする生物医学技術です。この技術は、細胞治療、再生医療、ドラッグ・デリバリー・システムなど、様々な医療応用の可能性を秘めています。その主な必要性は、移植された細胞に免疫保護を提供する能力に起因しており、これは糖尿病、がん、神経変性疾患などの治療にとって極めて重要です。その応用範囲は広く、研究や治療の実践を含み、カプセル化された細胞は治療薬の放出、細胞置換療法、生体人工臓器の作成に使用されます。最終用途のセグメントには、主に病院、研究機関、高度な治療法に重点を置く製薬会社などが含まれます。

市場成長を促進する主な要因としては、バイオテクノロジーとヘルスケアへの投資の増加、生体材料と生体適合性の進歩、革新的な治療法を必要とする慢性疾患の有病率の上昇などが挙げられます。同時に、意識の高まりとヘルスケア支出の増加が、さらなる需要に拍車をかけています。しかし、生物学的適合性、拡張性、規制上のハードルといった課題が大きな制約となっています。市場開拓企業は、高い研究開発コストとカプセル内の細胞生存率維持の複雑さを克服しなければならないです。

潜在的なビジネスチャンスは、より洗練された生体材料やカプセル化技術の開発、個別化医療、研究室の進歩を臨床現場に反映させるための産学連携にあります。また、食品や栄養補助食品分野での生細胞カプセル化の可能性への関心も高まっています。企業は、ナノカプセル化や生分解性ポリマーなどの革新的分野に注目すべきです。継続的な研究と高度な治療に対する急増する需要に牽引され、市場は中成長から高成長の傾向にあるとの調査結果が出ています。既存の課題を克服するには、戦略的パートナーシップと強固な規制戦略が不可欠です。市場はダイナミックであり、主に技術の進歩と革新的な治療法に対する明確な需要によって推進され、有望でありながら競合情勢を確実なものにしています。

市場力学：急速に進化する生細胞カプセル化市場の主要市場インサイトを公開

生細胞カプセル化市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 対象疾患、ジフテリア、破傷風、ポリオ、麻疹、結核などの罹患率の増加
  • 技術の進歩と相まって、新規製品開発を支援するための官民投資を通じた投資
  • 疾病管理におけるカプセル化細胞の臨床的役割に関する社会的認識
• 市場抑制要因
  • 高い生産コスト
• 市場機会
  • 新規ドラッグデリバリーシステムへの注目
  • 生細胞カプセル化開発のための継続的研究活動
• 市場の課題
  • 代替療法の入手可能性と採用

ポーターの5つの力：生細胞カプセル化市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：生細胞カプセル化市場における外部からの影響の把握

外部マクロ環境要因は、生細胞カプセル化市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析生細胞カプセル化市場における競合情勢の把握

生細胞カプセル化市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス生細胞カプセル化市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、生細胞カプセル化市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨生細胞カプセル化市場における成功への道筋を描く

生細胞カプセル化市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 対象疾患、ジフテリア、破傷風、ポリオ、麻疹、結核などの対象疾患の発生率の増加
    • 官民投資による技術革新と組み合わせた新製品開発を支援する投資
    • 疾患管理におけるカプセル化細胞の臨床的役割に関する一般の認識
  • 抑制要因
    • 生産コストが高い
  • 機会
    • 新しいドラッグデリバリーシステムに焦点を当てる
    • 生細胞カプセル化の開発に向けた継続的な調査活動
  • 課題
    • 代替療法の利用可能性と採用
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 生細胞カプセル化市場テクニック

• 同軸気流
• 静電気による滴下
• ジェットカッティング
• 液体ジェットの分解
• 回転ディスク噴霧
• シンプルなドリッピング
• 振動ジェット技術

第7章 生細胞カプセル化市場ポリマー

• 2-ヒドロキシエチルメタクリレートおよびメチルメタクリレート
• アルギン酸
• 硫酸セルロース
• キトサン
• PAN-PVC
• シリカ質カプセル

第8章 生細胞カプセル化市場：用途別

• 細胞移植
• ドラッグデリバリー
• プロバイオティクス
• 再生医療
• 調査

第9章 南北アメリカの生細胞カプセル化市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の生細胞カプセル化市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの生細胞カプセル化市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Austrianova Singapore Pte Ltd
• Beta-O2 Technologies Ltd.
• Biotime, Inc.
• Blacktrace Holdings Ltd.
• BUCHI Labortechnik AG
• Defymed SAS
• Evonik Industries AG
• Kadimastem
• Living Cell Technologies Limited.
• Merck KGaA
• Neurotech Holdings, LLC.
• Pharmacyte Biotech, Inc.
• Reed Pacific Pty Limited
• Sernova Corporation
• Sigilon Therapeutics, Inc.
• Viacyte, Inc.

LIST OF FIGURES

• FIGURE 1. LIVE CELL ENCAPSULATION MARKET RESEARCH PROCESS
• FIGURE 2. LIVE CELL ENCAPSULATION MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS LIVE CELL ENCAPSULATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS LIVE CELL ENCAPSULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES LIVE CELL ENCAPSULATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES LIVE CELL ENCAPSULATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC LIVE CELL ENCAPSULATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC LIVE CELL ENCAPSULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA LIVE CELL ENCAPSULATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA LIVE CELL ENCAPSULATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. LIVE CELL ENCAPSULATION MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. LIVE CELL ENCAPSULATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. LIVE CELL ENCAPSULATION MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. LIVE CELL ENCAPSULATION MARKET DYNAMICS
• TABLE 7. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY COAXIAL AIRFLOW, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY ELECTROSTATIC DRIPPING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY JET CUTTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY LIQUID-JET BREAK-UP, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY ROTATING DISK ATOMIZATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY SIMPLE DRIPPING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY VIBRATING-JET TECHNIQUE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY 2-HYDROXYETHYL METHACRYLATE & METHYL METHACRYLATE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY ALGINATE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY CELLULOSE SULFATE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY CHITOSAN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY PAN-PVC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY SILICEOUS ENCAPSULATES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY CELL TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY PROBIOTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL LIVE CELL ENCAPSULATION MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS LIVE CELL ENCAPSULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. CANADA LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 39. CANADA LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 40. CANADA LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 43. MEXICO LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES LIVE CELL ENCAPSULATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC LIVE CELL ENCAPSULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 52. AUSTRALIA LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 53. AUSTRALIA LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 54. AUSTRALIA LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. CHINA LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 56. CHINA LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 57. CHINA LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. INDIA LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 59. INDIA LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 60. INDIA LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. INDONESIA LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 62. INDONESIA LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 63. INDONESIA LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. JAPAN LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 65. JAPAN LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 66. JAPAN LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. MALAYSIA LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 68. MALAYSIA LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 69. MALAYSIA LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. PHILIPPINES LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 71. PHILIPPINES LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 72. PHILIPPINES LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. SINGAPORE LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 74. SINGAPORE LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 75. SINGAPORE LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. SOUTH KOREA LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 77. SOUTH KOREA LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 78. SOUTH KOREA LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. TAIWAN LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 80. TAIWAN LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 81. TAIWAN LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. THAILAND LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 83. THAILAND LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 84. THAILAND LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. VIETNAM LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 86. VIETNAM LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 87. VIETNAM LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. EUROPE, MIDDLE EAST & AFRICA LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 89. EUROPE, MIDDLE EAST & AFRICA LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 90. EUROPE, MIDDLE EAST & AFRICA LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. EUROPE, MIDDLE EAST & AFRICA LIVE CELL ENCAPSULATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 92. DENMARK LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 93. DENMARK LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 94. DENMARK LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. EGYPT LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 96. EGYPT LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 97. EGYPT LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. FINLAND LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 99. FINLAND LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 100. FINLAND LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. FRANCE LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 102. FRANCE LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 103. FRANCE LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. GERMANY LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 105. GERMANY LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 106. GERMANY LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. ISRAEL LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 108. ISRAEL LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 109. ISRAEL LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. ITALY LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 111. ITALY LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 112. ITALY LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. NETHERLANDS LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 114. NETHERLANDS LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 115. NETHERLANDS LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. NIGERIA LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 117. NIGERIA LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 118. NIGERIA LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. NORWAY LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 120. NORWAY LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 121. NORWAY LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 122. POLAND LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 123. POLAND LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 124. POLAND LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. QATAR LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 126. QATAR LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 127. QATAR LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. RUSSIA LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 129. RUSSIA LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 130. RUSSIA LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. SAUDI ARABIA LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 132. SAUDI ARABIA LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 133. SAUDI ARABIA LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. SOUTH AFRICA LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 135. SOUTH AFRICA LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 136. SOUTH AFRICA LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. SPAIN LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 138. SPAIN LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 139. SPAIN LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. SWEDEN LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 141. SWEDEN LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 142. SWEDEN LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. SWITZERLAND LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 144. SWITZERLAND LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 145. SWITZERLAND LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. TURKEY LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 147. TURKEY LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 148. TURKEY LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 149. UNITED ARAB EMIRATES LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 150. UNITED ARAB EMIRATES LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 151. UNITED ARAB EMIRATES LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 152. UNITED KINGDOM LIVE CELL ENCAPSULATION MARKET SIZE, BY TECHNIQUES, 2018-2030 (USD MILLION)
• TABLE 153. UNITED KINGDOM LIVE CELL ENCAPSULATION MARKET SIZE, BY POLYMER, 2018-2030 (USD MILLION)
• TABLE 154. UNITED KINGDOM LIVE CELL ENCAPSULATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 155. LIVE CELL ENCAPSULATION MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 156. LIVE CELL ENCAPSULATION MARKET, FPNV POSITIONING MATRIX, 2023

The Live Cell Encapsulation Market was valued at USD 312.29 million in 2023, expected to reach USD 325.89 million in 2024, and is projected to grow at a CAGR of 4.44%, to USD 423.54 million by 2030.

Live cell encapsulation is a biomedical technology where live cells are enclosed within semi-permeable membranes or capsules, protecting them from the host's immune system while allowing the exchange of molecules. This technique holds potential in various medical applications such as cell therapy, regenerative medicine, and drug delivery systems. Its primary necessity stems from its ability to provide immune protection to transplanted cells, which is crucial for treating conditions like diabetes, cancer, and neurodegenerative diseases. The application scope is broad, involving research and therapeutic practice, where encapsulated cells can be used to release therapeutic agents, offer cell replacement therapy, and create bioartificial organs. End-use segments primarily include hospitals, research institutes, and pharmaceutical companies focusing on advanced therapeutic methods.

Key factors driving market growth include increasing investments in biotechnology and healthcare, advancements in biomaterials and biocompatibility, and the rising prevalence of chronic diseases requiring innovative treatment modalities. Simultaneously, growing awareness and healthcare expenditure are spurring further demand. However, challenges such as biological compatibility, scalability, and regulatory hurdles pose significant limitations. Market players must navigate high research and development costs and the complexity of maintaining cell viability within capsules.

Potential opportunities lie in developing more sophisticated biomaterials and encapsulation techniques, personalized medicine, and collaborations between industry and academia to translate laboratory advancements into clinical settings. There's also a growing interest in the potential of live cell encapsulation in food and nutraceutical sectors. Businesses should focus on areas of innovation like nanoencapsulation and biodegradable polymers. Insights suggest a market leaning towards moderate to high-growth trends, driven by continuous research and the burgeoning demand for advanced therapies. Strategic partnerships and robust regulatory strategies will be critical for overcoming existing challenges. The market is dynamic, primarily propelled by technological advances and a clear demand for innovative treatment methods, ensuring a promising yet competitive landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Live Cell Encapsulation Market

The Live Cell Encapsulation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing incidences of target diseases including target diseases, diphtheria, tetanus, poliomyelitis, measles, and tuberculosis
  • Investment via public-private investments to support the novel product development coupled with technology advancements
  • Public awareness related to the clinical role of encapsulated cells in disease management
• Market Restraints
  • High production cost
• Market Opportunities
  • Focus on Novel drug delivery systems
  • Ongoing research activities for development of live cell encapsulation
• Market Challenges
  • Availability and adoption of alternative therapies

Porter's Five Forces: A Strategic Tool for Navigating the Live Cell Encapsulation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Live Cell Encapsulation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Live Cell Encapsulation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Live Cell Encapsulation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Live Cell Encapsulation Market

A detailed market share analysis in the Live Cell Encapsulation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Live Cell Encapsulation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Live Cell Encapsulation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Live Cell Encapsulation Market

A strategic analysis of the Live Cell Encapsulation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Live Cell Encapsulation Market, highlighting leading vendors and their innovative profiles. These include Austrianova Singapore Pte Ltd, Beta-O2 Technologies Ltd., Biotime, Inc., Blacktrace Holdings Ltd., BUCHI Labortechnik AG, Defymed SAS, Evonik Industries AG, Kadimastem, Living Cell Technologies Limited., Merck KGaA, Neurotech Holdings, LLC., Pharmacyte Biotech, Inc., Reed Pacific Pty Limited, Sernova Corporation, Sigilon Therapeutics, Inc., and Viacyte, Inc..

Market Segmentation & Coverage

This research report categorizes the Live Cell Encapsulation Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Techniques, market is studied across Coaxial Airflow, Electrostatic Dripping, Jet Cutting, Liquid-Jet Break-Up, Rotating Disk Atomization, Simple Dripping, and Vibrating-Jet Technique.
• Based on Polymer, market is studied across 2-Hydroxyethyl Methacrylate & Methyl Methacrylate, Alginate, Cellulose Sulfate, Chitosan, PAN-PVC, and Siliceous Encapsulates.
• Based on Application, market is studied across Cell Transplantation, Drug Delivery, Probiotics, Regenerative Medicine, and Research.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing incidences of target diseases including target diseases, diphtheria, tetanus, poliomyelitis, measles, and tuberculosis
    • 5.1.1.2. Investment via public-private investments to support the novel product development coupled with technology advancements
    • 5.1.1.3. Public awareness related to the clinical role of encapsulated cells in disease management
  • 5.1.2. Restraints
    • 5.1.2.1. High production cost
  • 5.1.3. Opportunities
    • 5.1.3.1. Focus on Novel drug delivery systems
    • 5.1.3.2. Ongoing research activities for development of live cell encapsulation
  • 5.1.4. Challenges
    • 5.1.4.1. Availability and adoption of alternative therapies
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Live Cell Encapsulation Market, by Techniques

• 6.1. Introduction
• 6.2. Coaxial Airflow
• 6.3. Electrostatic Dripping
• 6.4. Jet Cutting
• 6.5. Liquid-Jet Break-Up
• 6.6. Rotating Disk Atomization
• 6.7. Simple Dripping
• 6.8. Vibrating-Jet Technique

7. Live Cell Encapsulation Market, by Polymer

• 7.1. Introduction
• 7.2. 2-Hydroxyethyl Methacrylate & Methyl Methacrylate
• 7.3. Alginate
• 7.4. Cellulose Sulfate
• 7.5. Chitosan
• 7.6. PAN-PVC
• 7.7. Siliceous Encapsulates

8. Live Cell Encapsulation Market, by Application

• 8.1. Introduction
• 8.2. Cell Transplantation
• 8.3. Drug Delivery
• 8.4. Probiotics
• 8.5. Regenerative Medicine
• 8.6. Research

9. Americas Live Cell Encapsulation Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Live Cell Encapsulation Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Live Cell Encapsulation Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Austrianova Singapore Pte Ltd
• 2. Beta-O2 Technologies Ltd.
• 3. Biotime, Inc.
• 4. Blacktrace Holdings Ltd.
• 5. BUCHI Labortechnik AG
• 6. Defymed SAS
• 7. Evonik Industries AG
• 8. Kadimastem
• 9. Living Cell Technologies Limited.
• 10. Merck KGaA
• 11. Neurotech Holdings, LLC.
• 12. Pharmacyte Biotech, Inc.
• 13. Reed Pacific Pty Limited
• 14. Sernova Corporation
• 15. Sigilon Therapeutics, Inc.
• 16. Viacyte, Inc.